Avalo Therapeutics (AVTX) Cash from Investing Activities (2016 - 2026)
Avalo Therapeutics posted quarterly Cash from Investing Activities of $25.5 million for Q1 2026, up 962.27% on a QoQ basis from $2.4 million in Q4 2025.
Avalo Therapeutics (AVTX) has 11 years of Cash from Investing Activities data on file, last reported at $25.5 million in Q1 2026.
- For the quarter ending Q1 2026, Cash from Investing Activities changed N/A year-over-year to $25.5 million; the trailing twelve-month figure through Mar 2026 stood at -$56.2 million (changed N/A YoY), and the FY2025 full-year result was -$81.7 million, down 23055.06% from the prior year.
- Cash from Investing Activities for Q1 2026 stood at $25.5 million, up from $2.4 million in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $25.5 million in Q1 2026 and bottomed at -$70.9 million in Q2 2025.
- The 5-year median for Cash from Investing Activities is -$47500.0 (2022), against an average of -$7.0 million.
- The widest annual swing landed in 2022, when Cash from Investing Activities jumped 51.85%; it then surged 367.67% in 2024.
- A 5-year view of Cash from Investing Activities shows it stood at -$39000.0 in 2022, then tumbled by 241.03% to -$133000.0 in 2023, then soared by 367.67% to $356000.0 in 2024, then soared by 574.44% to $2.4 million in 2025, then soared by 962.27% to $25.5 million in 2026.
- The last three Cash from Investing Activities figures came in at $25.5 million (Q1 2026), $2.4 million (Q4 2025), and -$13.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.89 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 638.50 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -431.90 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -428.90 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -25.54 Mn |
| 10 | Avalo Therapeutics | 317.29 Mn | 317.29 Mn | - | 25.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 25.51 Mn |
| Mar 31, 2026 | 25.51 Mn |
| Dec 31, 2025 | 2.40 Mn |
| Dec 31, 2025 | 2.40 Mn |
| Sep 30, 2025 | -13.26 Mn |
| Sep 30, 2025 | -13.26 Mn |
| Jun 30, 2025 | -70.86 Mn |
| Jun 30, 2025 | -70.86 Mn |
| Mar 31, 2024 | 356,000.00 |
| Mar 31, 2024 | 356,000.00 |
| Mar 31, 2023 | -133,000.00 |
| Mar 31, 2023 | -133,000.00 |
| Sep 30, 2022 | -39,000.00 |
| Sep 30, 2022 | -39,000.00 |
| Jun 30, 2022 | -56,000.00 |
| Jun 30, 2022 | -56,000.00 |
| Dec 31, 2021 | -11,000.00 |
| Dec 31, 2021 | -11,000.00 |
| Sep 30, 2021 | -81,000.00 |
| Sep 30, 2021 | -81,000.00 |
| Mar 31, 2021 | -21,000.00 |
| Mar 31, 2021 | -21,000.00 |
| Dec 31, 2020 | -391,000.00 |
| Dec 31, 2020 | -391,000.00 |
| Sep 30, 2020 | -63,000.00 |
| Sep 30, 2020 | -63,000.00 |
| Jun 30, 2020 | 12.84 Mn |
| Jun 30, 2020 | 12.84 Mn |
| Mar 31, 2020 | -1.25 Mn |
| Mar 31, 2020 | -1.25 Mn |
| Dec 31, 2019 | -180,991.00 |
| Dec 31, 2019 | -180,991.00 |
| Sep 30, 2019 | -5,085.00 |
| Sep 30, 2019 | -5,085.00 |
| Jun 30, 2019 | -90,957.00 |
| Jun 30, 2019 | -90,957.00 |
| Mar 31, 2019 | -165,969.00 |
| Mar 31, 2019 | -165,969.00 |
| Dec 31, 2018 | -499,357.00 |
| Dec 31, 2018 | -499,357.00 |
| Sep 30, 2018 | 1.39 Mn |
| Sep 30, 2018 | 1.39 Mn |
| Jun 30, 2018 | -6,707.00 |
| Jun 30, 2018 | -6,707.00 |
| Mar 31, 2018 | -19,225.00 |
| Mar 31, 2018 | -19,225.00 |
| Dec 31, 2017 | -18.90 Mn |
| Dec 31, 2017 | -18.90 Mn |
| Sep 30, 2017 | -6,189.00 |
| Sep 30, 2017 | -6,189.00 |
| Mar 31, 2017 | -1,801.00 |
| Mar 31, 2017 | -1,801.00 |
| Dec 31, 2016 | -9,237.00 |
| Dec 31, 2016 | -9,237.00 |
| Sep 30, 2016 | -6,489.00 |
| Sep 30, 2016 | -6,489.00 |
| Jun 30, 2016 | -10,259.00 |
| Jun 30, 2016 | -10,259.00 |
| Mar 31, 2016 | -8,898.00 |
| Mar 31, 2016 | -8,898.00 |